Lexogen Announces the "Win your SENSE Study" Award

Lexogen’s new SENSE mRNA-Seq kit gives researchers the power to analyze antisense transcription like never before.

By eliminating the causes of false-positive antisense reads created by conventional RNA-Seq kits, SENSE delivers unprecedented strand-specificity (>99.9%) and gives you the confidence that every antisense read originates from an antisense transcript.

Lexogen is eager to work with you on exciting projects. We therefore invite you to submit a research proposal in which you describe how you would take advantage of the extreme strand-specificity that SENSE provides. The winning proposals will be completely supported by Lexogen (this includes sample preparation, sequencing, and any required bioinformatical support).

Please apply by sending your project proposal and short description of your research interests to award(at)lexogen.com. The application deadline is March 31st, 2013. Proposals will be reviewed by an in-house committee and winners will be announced on April 8th.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.